Figure 2. FK506 (tacrolimus) binding
protein 51 overexpression increases protein levels of nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-κB), activated
NF-κB, and decreased protein levels of inhibitory molecule, IKappaB
(IκB). A: FK506 Binding Protein 51 (FKBP51) overexpression
significantly increased NF-κB p65 and phospho NF-κB p65 protein levels
while significantly decreasing IκBα protein levels. The 661w neuronal
cell culture—stably transfected with an FKBP51 expression
vector—increased FKBP51 protein levels fivefold, compared to the 661w
neuronal cell culture stably transfected with the parental empty
vector. (-) represents stably transfected empty vector control cells
and (+) represents stably transfected FKBP51 overexpression cells. B,
C: The increase in FKBP51 expression caused a significant
increase in protein levels of NF-κB p65 and activated NF-κB p65 (NF-κB
p65: n=6, *p=0.002; phospho NF-κB p65: n=6, *p=0.002). D: The
increase in FKBP51 expression caused a significant decrease in protein
levels of IκBα (IκBα: n=3, *p=0.044). The loading controls were
β-tubulin for IκBα and NF-κB p65, while GAPDH was used for FKBP51 and
for activated NF-κB p65. Significance was obtained through one-way
ANOVA (ANOVA) and the Mann–Whitney test. Error bars represent SEM.